Benjamin N. Greener
- Infectious Diseases top 10%
- Virology top 5%
- Molecular Biology
- Epidemiology
- Immunology
- Co-authors
- Jessica AdamsAngela D. M. KashubaMatthew D. WeitzmanIñigo NarvaizaDavid J. PintelEric C. LogueNathaniel R. LandauYoshiyuki Hakata
- Topics
- HIV Research and Treatment (4 papers)Immunodeficiency and Autoimmune Disorders (3 papers)HIV/AIDS drug development and treatment (3 papers)
- Journals
- The Lancet Infectious DiseasesPLoS PathogensJAIDS Journal of Acquired Immune Deficiency Syndromes
- Partner nations
- United StatesJapan
In The Last Decade
Benjamin N. Greener
7 papers receiving 309 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Infectious Diseases 175
- Virology 131
- Molecular Biology 112
- Epidemiology 93
- Immunology 58
Countries citing papers authored by Benjamin N. Greener
This map shows the geographic impact of Benjamin N. Greener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin N. Greener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin N. Greener more than expected).
Fields of papers citing papers by Benjamin N. Greener
This network shows the impact of papers produced by Benjamin N. Greener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin N. Greener. The network helps show where Benjamin N. Greener may publish in the future.
Co-authorship network of co-authors of Benjamin N. Greener
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin N. Greener. A scholar is included among the top collaborators of Benjamin N. Greener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin N. Greener. Benjamin N. Greener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trialbreakdown → | 63 |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 21 | |
| 5 | 47 | |
| 6 | 28 | |
| 7 | 39 | |
| 8 | 115 |
About Benjamin N. Greener
Benjamin N. Greener is a scholar working on Virology, Infectious Diseases and Immunology, having authored 8 papers that have together received 321 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Virology (131 citations), Infectious Diseases (175 citations) and Immunology (58 citations). Benjamin N. Greener has collaborated with scholars based in United States and Japan. Frequent co-authors include Jessica Adams, Angela D. M. Kashuba, Matthew D. Weitzman, Iñigo Narvaiza, David J. Pintel, Eric C. Logue, Nathaniel R. Landau, Yoshiyuki Hakata, James Mond and Julie B. Dumond. Their work appears in journals such as The Lancet Infectious Diseases, PLoS Pathogens and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.